Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
Professional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How neural operators, GPU acceleration, and physics-informed AI are cutting turbulence simulation times by up to 1000×. The 2026 technology landscape from PatSnap.
Article | Report How Ocular Therapeutix's axitinib intravitreal implant (OTX-TKI) competes in the bioerodible depot vs. port delivery race for wet AMD. Patent landscape analysis.
Article | Report How do engineers choose between sintering and hot pressing for advanced technical ceramics? Explore key selection criteria, microstructural outcomes, and industrial applications.
Article | Report Prime editing's 2026 technology landscape: pegRNA engineering, off-target safety, 56,000 ClinVar variants, delivery bottlenecks, and the race to first-in-human trials.
Article | Report Spatial genomics maps gene expression to tissue locations, reshaping oncology, neuroscience and biodiversity. Explore the 2026 technology landscape and key innovation signals.
Article | Report Zilebesiran (ALN-AGT) targets hepatic AGT via GalNAc-siRNA to suppress RAAS upstream. Explore Phase 3 KARDIA data, IP landscape, and competitive threats in resistant hypertension.
Article | Report How AI-powered defect classification improves first-pass yield in PCB assembly inspection—covering AOI, deep learning, solder joint detection, and false-call reduction.
Article | Report A 2026 patent and literature landscape of autonomous vehicle HD map technology — covering map generation, V2X updates, interoperability, and AI-driven utilization.
Article | Report How engineers validate sealing integrity of implantable medical device enclosures under ISO 11607 sterile barrier requirements — methods, standards, and tools.
Article | Report CT-388 and petrelintide are competing in next-generation obesity pharmacotherapy. Explore the GLP-1/GIP dual agonist and amylin receptor agonist landscape, IP signals, and clinical race.
Article | Report A 2026 technology landscape of extracellular vesicle drug delivery: scaffold proteins, hybrid systems, CNS delivery, and the IP race shaping the field.
Article | Report Amycretin's Phase III launch signals a new era beyond semaglutide. Explore clinical data, patent IP, and competitive positioning of Novo Nordisk's dual agonist.
Article | Report 2026 landscape of floating offshore wind mooring technology: catenary, TLP, synthetic lines, shared anchors, and active repositioning patents analysed.
Article | Report How AI is transforming the way engineers monitor competitive patent filings in fast-moving tech sectors — from NLP classification to real-time alerts.
Article | Report Survodutide (BI 456906) is Boehringer Ingelheim's GLP-1/glucagon dual agonist challenging Lilly and Novo Nordisk in obesity. Explore the mechanism, pipeline, and competitive landscape.